Product
Crestor
Aliases
Crestor 10 mg, Rosuvastatin 10 mg
3 clinical trials
5 indications
Indication
HypertriglyceridemiaIndication
lipid metabolism disorderIndication
DyslipidemiaIndication
HypercholesterolemiaIndication
Combined HyperlipidemiaClinical trial
Phase III, National, Multicenter, Randomized, Double Blind Clinical Trial, to Evaluate the Efficacy and Safety of Cipros 10 Association on Dyslipidemia TreatmentStatus: Recruiting, Estimated PCD: 2024-06-30
Clinical trial
Phase III, National, Multicenter, Randomized, Double-blind Clinical Trial, to Evaluate the Efficacy and Safety of Cipros 20 Association on the Dyslipidemia TreatmentStatus: Recruiting, Estimated PCD: 2023-11-30
Clinical trial
Open, Randomized, 2-Group, 2-Period, Fasting, Single-Dose, Crossover Study to Evaluate the Bioequivalence of "Crecheck Tablet 2.5 mg (Rosuvastatin Calcium)" of Hanlim Pharm. Co., Ltd. and "Crestor Tablet 5 mg (Rosuvastatin Calcium)" of AstraZeneca Korea Co., Ltd. in Healthy Adult SubjectsStatus: Completed, Estimated PCD: 2023-12-07